Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2016-07-31
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sienna and Sentimag in Sentinel Lymph Node Biopsy
NCT03036475
Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients
NCT06169072
SentiMag® Intraoperative Comparison in Breast Cancer
NCT02336737
Sentinel Node Localization and Staging with Low Dose Superparamagnetic Iron Oxide
NCT05359783
Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes
NCT05122585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Native 1,5 Tesla breast MRI group
From all patients a 1,5 Tesla MRI of the breast will be obtained
Native 1,5 Tesla breast MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Native 1,5 Tesla breast MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* informed consent
* no contraindications for MRI scan
exclusion:
* contraindications for MRI scan
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Baden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cornelia Leo
Head, Breast Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Baden
Baden, Canton of Aargau, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-00808
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.